Stem from nature, Return to nature
Animal Health
5-Aminolevulinic acid（5-ALA）
γ-Aminobutyric acid（GABA）
01
Green Agriculture
5-Aminolevulinic acid（5-ALA）
γ-Aminobutyric acid（GABA）
Monopotassium phosphate
02
Pharmaceutical Raw Materials
L-5-Methyltetrahydrofolate calcium
Apigenin
D-chiro-inositol
NR (Nicotinamide Riboside)
NADP/ NADP - 2Na/ NMN
Nicotinamide Adenine Dinucleotide (NAD+)
γ-Aminobutyric acid（GABA）
03
Cosmetics raw materials
Calcium propionate
Hexamidine Diisethionate
Pro-Xylane
Ectoin
04
Sconry Biopharma (Shanghai) Co., Ltd. Business Field
Deep Integration of Research, Production, and Sales
Promoting Industry Chain Transformation and Upgrading
Project Initiation
Design
Construction
Industrialization
Optimization
Testing
More Innovative Technical Solutions
Higher Research Efficiency
Faster Market Response
More Comprehensive Industrial Layout
Complete Synthetic Biology Technology Platform
Genetic Engineering
Metabolic Engineering
Enzyme Engineering
Fermentation Engineering
Chemical Synthesis
High Throughput ScreeningNews · Information
Synthetic Biology Company 'Sconry Biopharma' Completes Pre-A Round Financing, Focusing on Biological Fermentation and Enzyme Catalysis Technology Research, with Strategic Layout in Bio-based Materials and Health Sectors
In July 2024, Sconry Biopharma (Shanghai) Co., Ltd. successfully completed its Pre-A round of financing, co-invested by Mr. He Haichao, Chairman of JW Machinery and Chairman of JW Fund, and Mr. Xie Youbang and Mr. Fang Ying, founding partners of JW Fund. This round of financing will be used for research and development in biological fermentation and enzyme catalysis technology, with a strategic focus on bio-based materials and the health sector.